すべての画像(2)
About This Item
実験式（ヒル表記法）:
C22H42O6
CAS番号:
分子量:
402.57
EC Number:
MDL番号:
UNSPSCコード:
12162002
PubChem Substance ID:
NACRES:
NA.23
おすすめの製品
フォーム
solid
品質水準
mp
46-47 °C (lit.)
HLB
6
SMILES記法
CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC[C@H](O)[C@H]1O
InChI
1S/C22H42O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(25)27-17-19(24)22-21(26)18(23)16-28-22/h18-19,21-24,26H,2-17H2,1H3/t18-,19?,21+,22+/m0/s1
InChI Key
IYFATESGLOUGBX-NDUCAMMLSA-N
類似した製品をお探しですか？ 訪問 製品比較ガイド
法的情報
Span is a registered trademark of Croda International PLC
保管分類コード
11 - Combustible Solids
WGK
WGK 1
引火点(°F)
235.4 °F - closed cup
引火点(℃)
113 °C - closed cup
個人用保護具 (PPE)
dust mask type N95 (US), Eyeshields, Gloves
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
388920-BULK:
388920-1KG:
388920-250G:
388920-VAR:
この製品を見ている人はこちらもチェック
Omer Salman Qureshi et al.
Journal of microencapsulation, 34(3), 250-261 (2017-05-31)
The aim of this study was to develop docetaxel-incorporated lipid nanoparticles (DTX-NPs) to improve the pharmacokinetic behaviour of docetaxel (DTX) after oral and parenteral administration via sustained release. DTX-NPs were prepared by nanotemplate engineering technique with palmityl alcohol as a
Yuta Miyazaki et al.
International journal of pharmaceutics, 528(1-2), 118-126 (2017-06-07)
A budesonide (BDS) suspension was obtained via advanced supercritical carbon dioxide (scCO
M Katsouli et al.
Food & function, 11(10), 8878-8892 (2020-09-29)
Multiple O1/W/O2 nanoemulsions and O1/W nanoemulsions fortified with CLA or CoQ10 were produced using extra virgin olive or olive pomace oil and were also incorporated with polyphenols extracted from olive kernel to enhance their kinetic and chemical stability. They were
Ahmed S Zidan et al.
Drug development and industrial pharmacy, 43(9), 1450-1459 (2017-04-20)
Dermal drug delivery system which localizes methotrexate (MTX) in the skin is advantageous in topical treatment of psoriasis. The aim of the current study was to understand dilution effects and formulation variability for the potential formation of niosomes from proniosome
Kamal K Upadhyay et al.
Drug development and industrial pharmacy, 33(6), 617-625 (2007-07-07)
The partial phase behavior, rheological, and drug release characteristics of an organogel (OG) composed of water, isooctane and sorbitan esters, sorbitan monopalmitate (Span-40) and poly(oxyethylene)sorbitan monostearate (Polysorbate-60) were studied. Phase diagrams showed decreasing areas of optically isotropic organogel region depending
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）